Brief: Immunovia Provides Update On COVID-19 Pandemic
May 27 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA PROVIDES FORTH UPDATE DURING COVID-19 PANDEMIC
* PLEASED TO HAVE RECEIVE GREEN-LIGHT TO REOPEN LAB IN
MARLBOROUGH
AND WE REMAIN ON TRACK TO HAVE FIRST-TO-MARKET WITH A VERY
ACCURATE TEST FOR EARLY DETECTION OF PANCREATIC CANCER
Source text for Eikon: ID:nWkr2Pq5ZJ
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study